EP 0790825 A1 19970827 - NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EYE DISORDERS
Title (en)
NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EYE DISORDERS
Title (de)
NK-1 REZEPTORANTAGONISTEN ZUR BEHANDLUNG VON AUGENERKRANKUNGEN
Title (fr)
ANTAGONISTES DU RECEPTEUR NK-1 DESTINES AU TRAITEMENT DE TROUBLES OCULAIRES
Publication
Application
Priority
- IB 9500811 W 19950929
- US 33695594 A 19941110
Abstract (en)
[origin: WO9614845A1] The present invention relates to a method of treating or preventing a disorder of the eye selected from glaucoma, ocular hypertension, miosis, excess lacrimation, hyperemia and breakdown of the blood aqueous barrier in mammals, including humans, using an NK-1 antagonist. It also relates to a method of treating or preventing such disorders in mammals, including humans, using certain quinuclidine derivatives, piperidine derivatives, pyrrolidine derivatives, azanorbornane derivatives, ethylene diamine derivatives and related compounds that are substance P receptor antagonists.
IPC 1-7
A61K 31/445; A61K 31/435; A61K 31/55; A61K 31/40; A61K 31/135; A61K 31/675
IPC 8 full level
A61K 31/135 (2006.01); A61K 31/137 (2006.01); A61K 31/40 (2006.01); A61K 31/438 (2006.01); A61K 31/451 (2006.01); A61K 31/4535 (2006.01); A61K 31/454 (2006.01); A61K 31/55 (2006.01); A61K 31/675 (2006.01); A61P 27/02 (2006.01); A61P 27/06 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A61K 31/137 (2013.01); A61K 31/40 (2013.01); A61K 31/438 (2013.01); A61K 31/439 (2013.01); A61K 31/451 (2013.01); A61K 31/4535 (2013.01); A61K 31/454 (2013.01); A61K 31/55 (2013.01); A61K 31/675 (2013.01); A61P 27/02 (2017.12); A61P 27/06 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 9614845A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9614845 A1 19960523; CA 2205016 A1 19960523; EP 0790825 A1 19970827; JP H10508837 A 19980902; MX 9703483 A 19970830
DOCDB simple family (application)
IB 9500811 W 19950929; CA 2205016 A 19950929; EP 95931373 A 19950929; JP 51586596 A 19950929; MX 9703483 A 19950929